Stanford University
Showing 19,001-19,100 of 36,179 Results
-
Amory B Lovins
Senior Precourt Scholar for Integrative Design and Energy Efficiency
Current Role at StanfordAdjunct Professor of Civil and Environmental Engineering, Sept 2019 – June 2024, then retitled Lecturer in CEE, with the same responsibilities, because the definition changed and Lovins lacks a PhD. Visiting Scholar, Precourt Institute for Energy.
-
Samuel Low
Ph.D. Student in Aeronautics and Astronautics, admitted Winter 2023
Ph.D. Minor, Electrical EngineeringBioSamuel Low is a Ph.D. candidate in the Stanford Space Rendezvous Laboratory, advised by Professor Simone D'Amico. Sam graduated from Stanford with an M.S. in Aeronautics and Astronautics (2023) and from the Singapore University of Technology and Design (SUTD) with a B.Sc. in Engineering Product Development (2018). His broad interests are in the guidance, navigation, control and autonomy of distributed space systems, such as formations and swarm satellites. His research focus is on enabling precise and robust state estimation between distributed spacecraft, centered on sensor/data fusion with carrier phase differential GNSS, with immediate applications to flight missions such as the VISORS and SWARM-EX missions. He had worked previously in DSO National Laboratories, Singapore, on space mission design and on developing navigation algorithms for Singapore's first formation flying satellite mission. He received the DSO Postgraduate Fellowship (2021), the Tan Kah Kee Postgraduate Scholarship (2021), the DSO SOAR Scholarship (2017), and the Asian Leadership Program Scholarship (2015-2018) jointly awarded by SUTD and Zhejiang University. In his spare time, he enjoys photography, painting, and outdoor activities.
-
Momoyo Lowdermilk
Advanced Lecturer
Current Research and Scholarly InterestsActive Learning, CBI, Proficiency-Based Instruction & Learners Autonomy
-
Alarice Cheng-Yi Lowe
Associate Professor of Pathology
BioDr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of new technology to improve clinical and molecular diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Anson Lowe
Associate Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Current Research and Scholarly InterestsThe laboratory is focused on the relationship between injury, wound healing, and cancer. Esophageal, gastric, and pancreatic cancers are a focus. We are particularly interested in the regulation of cell signaling by EGFR, the EGF receptor. In addition to cancer pathogenesis, active projects include the development of new diagnostic assays and drugs.
-
Chenery Lowe
Postdoctoral Scholar, Biomedical Ethics
BioChenery Lowe, Ph.D., CGC, is a genetic counselor and healthcare communication researcher. She received her ScM in Genetic Counseling from the Johns Hopkins University/ National Institutes of Health Genetic Counseling Training Program in 2018. Chenery received her Ph.D. in Social and Behavioral Sciences from Johns Hopkins Bloomberg School of Public Health in 2022, where she later served as an assistant scientist and academic director for the JHU/NIH genetic counseling program. Clinically, she has provided genetic counseling in immunology and adult oncology settings. She has taught graduate-level courses on interpersonal communication in health care, health literacy, and social and behavioral research in genetic counseling. Her research interests are in the areas of patient-provider communication, health equity, implicit bias, communication skills training interventions, and the ethics of interpersonal influence in medical care.
-
Christopher Lowe
John B. and Jean De Nault Professor of Marine Science at the Hopkins Marine Station
Current Research and Scholarly InterestsEvolution and development, specifically the evolution of the deuterostomes
-
Donald Lowe
Max Steineke Professor in Earth Sciences, Emeritus
Current Research and Scholarly InterestsClastic sedimentology, deep-water sedimentation mechanics and facies; Archean depositional systems and crustal development
-
Henry J. Lowe, MD
Associate Professor of Medicine (General Medical Disciplines) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy research in the field of biomedical informatics over the past 30 years has focused on the development of novel uses of information technology and computer science to improve human health. My current interests include the Electronic Health Record (EHR), biomedical knowledge representation, Internet applications in healthcare, clinical data warehouses, clinical data and text mining, academic social networking and the use of information technology to support clinical and translational research.
-
Norman Lowenbraun
Member, Cardiovascular Institute
BioDr Lowenbraun has been a practicing cardiologist in the Bay Area for over 25 years, having moved here after receiving his medical and specialty training on the East Coast. He believes offering the personal care of a community setting and empowering the patient in their healthcare decisions, combined with the resources of Stanford Hospital , offers his patients the best of both worlds.
-
Henry Lowood
Harold C. Hohbach Curator - History of Science & Technology; Film & Media, Humanities Resource Group
Current Role at StanfordHarold C. Hohbach Curator, Stanford Libraries
-
Katherine Lowry
Affiliate, Central Mgmt-Misc AR
BioKatherine Lowry is the Advanced Practice Provider Manager for the Lucile Packard Children's Hospital and Stanford Health Care nurse anesthesia and Stanford Health Care robotic surgery first assistant providers.
-
Robert Lowsky
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
-
Trevor Loy
Affiliate, Management Science and Engineering - Technology Ventures Program
BioTrevor Loy is the Managing Partner and Founder of Flywheel Ventures, a seed- and early-stage venture capital firm that has invested in emerging startup ecosystems for more than twenty-five years.
As an Adjunct Lecturer at Stanford, Trevor teaches entrepreneurial management and finance in the Management Science & Engineering Department, where he is affiliated with the Stanford Technology Ventures Program, a research and teaching center he helped create as a graduate student. He also teaches professional and executive education programs for the Stanford Engineering Center for Global & Online Education, as well as for global companies, universities, governments, and sovereign wealth funds.
Trevor shapes venture capital and entrepreneurship policy as a former director of the National Venture Capital Association and a current member of its Board Alumni Council. He also served as Chair of VenturePAC, the venture capital industry's national political action committee, and is a frequent expert witness in private litigation and government policymaking worldwide.
Before founding Flywheel, Trevor held founding, executive, and technical roles at startups including Brooktree, Gigabeat, and ParkingNet, as well as at large tech firms such as Intel, Rockwell, and Teradyne.
He holds a BS and MS in Electrical Engineering and an MS in Management Science & Engineering, all from Stanford University. -
Prashant Loyalka
Associate Professor of Education and Senior Fellow at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsPrashant's research focuses on examining/addressing inequalities in the education of youth and on understanding/improving the quality of education received by youth in a number of countries including China, India, Russia, and the United States. In the course of addressing educational inequalities, Prashant examines the consequences of tracking, financial and informational constraints, as well as social and psychological factors in highly competitive education systems. His work on understanding educational quality is built around research that assesses and compares student learning in higher education, high school and compulsory schooling. He furthermore conducts large-scale evaluations of educational programs and policies that seek to improve student outcomes.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Donghui Lu
Senior Scientist, SLAC National Accelerator Laboratory
BioDonghui Lu is a senior scientist at SLAC National Accelerator Laboratory. He is the deputy director of the Materials Science Division at the Stanford Synchrotron Radiation Lightsource leading the Soft X-ray Group. His research interests lie in studying quantum materials, such as high temperature superconductors, using high resolution angle-resolved photoemission spectroscopy. He is also an expert in developing modern synchrotron instrumentations, including cutting-edge soft x-ray beamlines and sophisticated endstations with versatile sample environments and materials synthesis capabilities.
-
Janice Lu
Clinical Professor, Medicine - Oncology
BioDr. Janice Lu is Clinical Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine. She specializes in the treatment of breast cancer, with expertise in hormone receptor–positive and HER2-positive disease, antibody-drug conjugates, and immunotherapy. Dr. Lu has led and contributed to multiple clinical trials, including playing a key role in the EMERALD trial, which resulted in FDA approval of the first oral SERD for ESR1-mutated ER+/HER2- metastatic breast cancer. Her translational research focuses on liquid biopsy, epigenetics, AI and multiomics approaches to treatment resistance. She has chaired national sessions on precision oncology and holds leadership roles with NRG Oncology and ASCO, including Vice-Chair of the NRG Immunotherapy Subcommittee and Track Leader for ASCO’s Developmental Therapeutics and Targeted Therapy Education Program. She has also served on committees for the National Comprehensive Cancer Network (NCCN) and the Southwest Oncology Group (SWOG).
Dr. Lu completed her Hematology and Oncology fellowship at New York University School of Medicine and earned a PhD in epigenetics under the mentorship of late Dr. David Allis, a pioneer in the field and 2018 Lasker Laureate. Prior to joining Stanford, she was Director of Breast Medical Oncology and led the Circulating Tumor Cell (CTC) Core Lab at Northwestern University Feinberg School of Medicine, before returning to the Bay Area to be with her family and to further expand research and patient-centered care. -
Junjie Lu
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2023
BioJunjie's research is centered on the social determinants of minority health, epidemiological methods, and clinical effectiveness. He is deeply committed to understanding the health disparities faced by minority populations. His clinical background helps bridge the gap between research and practical application, aiming to improve healthcare outcomes in real-world settings.
Junjie Lu earned a Master of Public Health degree from the Harvard T.H. Chan School of Public Health, where he concentrated on Health and Social Behavior. He also holds an MBBS and an MS from Shanghai University of Traditional Chinese Medicine. Junjie gained practical experience as an intern doctor at a university hospital for two years, during which he led a pilot randomized controlled trial on the effects of acupuncture on depressive symptoms. -
Lu Lu
Postdoctoral Scholar, Mechanical Engineering
BioDr. Lu Lu is currently a postdoctoral researcher at Stanford University. He received his B.S. and Ph.D. degrees from Ningbo University and Shanghai University in China in 2014 and 2019, respectively. He then worked as a postdoctoral researcher at Peking University from 2020 to 2022 before joining Stanford. His research interests focus on solid mechanics, with emphasis on mechanical instabilities, deployable structures, mechanics of intelligent soft materials, plate and shell theories, and nonlocal elasticity. He has published nearly 30 peer-reviewed papers in journals such as PNAS, JMPS, IJSS, AMR, IJMS, JAM, and PRSA, and received the ASME Melville Medal in 2024.
-
Pan Lu
Postdoctoral Scholar, Biomedical Data Sciences
Current Research and Scholarly InterestsMy research goal is to build machines that can reason and collaborate with humans for the common good. My primary research focuses on machine learning and NLP, particularly machine reasoning, mathematical reasoning, and scientific discovery:
1. Mathematical reasoning in multimodal and knowledge-intensive contexts
2. Tool-augmented large language models for planning, reasoning, and generation
3. Parameter-efficient fine-tuning for fondation models
4. AI for scientific reasoning and discovery -
Sydney X. Lu
Assistant Professor of Medicine (Hematology)
BioSydney Lu is an assistant professor and physician-scientist in the Division of Hematology, Department of Medicine with a broad interest in both normal and abnormal RNA processing in the context of normal physiology and disease states. The laboratory studies translational questions regarding the mechanistic basis of RNA processing abnormalities in malignant blood disorders, their implications for leukemogenesis and cancer biology, as well as resultant therapeutic opportunities.
As a physician, Sydney’s group is particularly focused on dissecting RNA processing abnormalities in primary patient samples and disease-relevant preclinical model systems. Lab members employ a variety of ‘wet-lab’ and computational approaches to study transcriptome abnormalities in (1) states of immune dysfunction, (2) myeloid blood cancers such as myelodysplastic syndromes and acute myeloid leukemia, and (3) lymphoid blood cancers such as chronic lymphocytic leukemia. Additional projects are focused on novel therapeutics, including multiple targeted agents which modulate RNA processing, for the selective treatment of these diseases.
Sydney’s research is/has been supposed by grant funding from the National Cancer Institute, Parker Institute for Cancer Immunotherapy, Leukemia & Lymphoma Society, Aplastic Anemia & Myelodysplastic Syndromes International Foundation, the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the Paula and Rodger Riney Foundation, the Doris Duke Charitable Foundation, The Gabrielles Angel Foundation for Cancer Research, and the Stanford Cancer Institute. -
Wan-Jin Lu
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioDr. Wan-Jin Lu is a Research Scientist in Dr. Phil Beachy's lab. Wan-Jin grew up in Taiwan, obtained her B.S. in Zoology at National Taiwan University and completed her PhD in Genetics and Development at UT Southwestern in the lab of Dr. John Abrams. Her Ph.D. research involved the identification of the evolutionary conserved function of the tumor suppressor gene p53 that ensures the quality control of germ cells. She then moved to the Bay Area, where she was a Damon Runyon Postdoctoral Fellow in the Institute of Stem Cell Biology and Regenerative Medicine in the Beachy lab. Her work currently focuses on understanding the function of Hedgehog signaling in taste receptor cell homeostasis and delineating the mechanisms of taste receptor regeneration after chemotherapy-induced loss.
Since 2017, she has been collaborating with Tabula Muris And Tabula Sapiens Consortium to investigate taste receptor stem cell renewal and regeneration in the Beachy lab. Her work has received funding support from California Institute of Regenerative Medicine (CIRM), Thomas and Stacey Siebel Foundation, and NIH (R21 and R01).
